This study has demonstrated that circulating exosomal circMYC is upregulated in patients with MM and is associated with BTZ response and relapse, which indicates that exosome circMYC has great potential as a biomarker for the diagnosis and prognosis of MM. Here, CASC3 is linked to Miyoshi myopathy.